Clinical Focus
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Health system–based clinical pathway improves pediatric lipid screening rates
2
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
3
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
4
Linaclotide demonstrates positive long-term safety
5
